MEI Pharma announced its first LTC purchase, sparking a rally for one of the oldest and well-established crypto coins.

Litecoin (LTC), one of the oldest and most recognized cryptocurrencies, is showing renewed strength in the market, surging ...

San Diego-based MEI Pharma (NASDAQ:MEIP) has acquired 929,548 Litecoin (CRYPTO: LTC) tokens, becoming the first U.S.-listed ...

MEI Pharma, a publicly traded pharmaceutical company, closed a $100 million private placement to turn itself into a litecoin ...

MEI Pharma unveils a $100M Litecoin treasury initiative, gaining Litecoin Foundation support and boosting shares 50% intraday ...

This strategic move, developed in partnership with GSR and with guidance provided by Litecoin Creator and MEI Board member Charlie Lee, marks the beginning of MEI’s broader institutional treasury ...

MEI Pharma unveils bold $100M Litecoin treasury plan with Titan, GSR, Litecoin Foundation, expanding altcoin adoption beyond traditional Bitcoin reserves.

MEI Pharma has become the first publicly traded company to adopt Litecoin (LTC) as a primary treasury reserve asset.

MEI Pharma (MEIP) just threw Wall Street a curveball by swapping part of its cash pile for Litecoin (LTC) and inviting ...

Analysts told Decrypt though ETF approval rumors are adding to optimism, it’s MEI Pharma’s buy-in last month that is really ...

MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange ...

MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange Charlie Lee, the Founder of ...